Last reviewed · How we verify

NCT03780153

The Norwegian Adult Achondroplasia Study

Completed Last updated 31 October 2022
What this trial tests

trial testing No intervention in Achondroplasia in 50 participants. Completed in 21 March 2022.

Timeline
1 March 2017
Primary endpoint
31 March 2019
21 March 2022

Quick facts

Lead sponsorSunnaas Rehabilitation Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date1 March 2017
Primary completion31 March 2019
Estimated completion21 March 2022
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Sunnaas Rehabilitation Hospital

Who can join

16 and older, any sex, with Achondroplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to investigate the Norwegian adult achondroplasia population regarding degree and extent of symptoms and clinical manifestations and how this population manages in daily life, including demographics, physical function, and work participation.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

  1. High prevalence of symptomatic spinal stenosis in Norwegian adults with achondroplasia: a population-based study.
    Fredwall SO, Steen U, de Vries O, Rustad CF, et al · · 2020 · cited 33× · PMID 32450891 · DOI 10.1186/s13023-020-01397-6
  2. Cardiovascular risk factors and body composition in adults with achondroplasia.
    Fredwall SO, Linge J, Leinhard OD, Kjønigsen L, et al · · 2021 · cited 17× · PMID 33204020 · DOI 10.1038/s41436-020-01024-6
  3. Obstructive sleep apnea in Norwegian adults with achondroplasia: a population-based study.
    Fredwall SO, Øverland B, Berdal H, Berg S, et al · · 2021 · cited 10× · PMID 33827611 · DOI 10.1186/s13023-021-01792-7
  4. Fat infiltration in the thigh muscles is associated with symptomatic spinal stenosis and reduced physical functioning in adults with achondroplasia.
    Fredwall SO, Linge J, de Vries O, Leinhard OD, et al · · 2023 · cited 5× · PMID 36814258 · DOI 10.1186/s13023-023-02641-5
  5. Hearing loss in Norwegian adults with achondroplasia.
    Fredwall SO, Åberg B, Berdal H, Savarirayan R, et al · · 2021 · cited 5× · PMID 34736503 · DOI 10.1186/s13023-021-02095-7

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

Other recruiting trials for Achondroplasia

Currently open trials in the same condition.

Other Sunnaas Rehabilitation Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03780153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing